Dadap, Baby Boy L.

HRN: 28-53-85  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CEFTAZIDIME 1GM (VIAL)
02/18/2026
02/25/2026
IV
70 Mg
Q 12
PSNB
Checking Initial Appropriateness 
02/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/20/2026
02/27/2026
IV
130 Mg
Q 8 Hours
T/C Neonatal Sepsis
Remove - Pending Acceptance
02/21/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/21/2026
03/14/2026
IV
8mg
2x A Week
NEONATAL SEPSIS
Remove - Pending Acceptance
02/21/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/21/2026
02/28/2026
IV
16mg
Q24H
Neonatal Sepsis
Remove - Pending Acceptance
03/15/2026
FLUCONAZOLE 50MG (CAP)
03/15/2026
04/04/2026
ORAL
10mg Pptab
2x/week For 3 Weeks
Neonatal Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: